Search by Drug Name or NDC
NDC 63323-0360-59 Calcium Gluconate 98 mg/mL Details
Calcium Gluconate 98 mg/mL
Calcium Gluconate is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is CALCIUM GLUCONATE MONOHYDRATE.
Product Information
| NDC | 63323-0360 |
|---|---|
| Product ID | 63323-360_3e4a7e0e-c7f4-4aa0-8c9c-0aa3fd7dc729 |
| Associated GPIs | 79100030002010 |
| GCN Sequence Number | 001356 |
| GCN Sequence Number Description | calcium gluconate VIAL 100 MG/ML INTRAVEN |
| HIC3 | C1F |
| HIC3 Description | CALCIUM REPLACEMENT |
| GCN | 03820 |
| HICL Sequence Number | 000585 |
| HICL Sequence Number Description | CALCIUM GLUCONATE |
| Brand/Generic | Generic |
| Proprietary Name | Calcium Gluconate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Calcium Gluconate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 98 |
| Active Ingredient Units | mg/mL |
| Substance Name | CALCIUM GLUCONATE MONOHYDRATE |
| Labeler Name | Fresenius Kabi USA, LLC |
| Pharmaceutical Class | Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA208418 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63323-0360-59 (63323036059)
| NDC Package Code | 63323-360-59 |
|---|---|
| Billing NDC | 63323036059 |
| Package | 25 VIAL, PLASTIC in 1 TRAY (63323-360-59) / 50 mL in 1 VIAL, PLASTIC (63323-360-03) |
| Marketing Start Date | 2017-06-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |